D78 vs T80.30XS
D78 (Intraoperative and postprocedural complications of the spleen) compared with T80.30XS (ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. T80.30XS carries an Excludes2 note covering D78: “intraoperative and postprocedural complications of specified body systems (D78.-, E36.-, E89.-, G97.3-, G97.4, H59.3-, H59.-, H95.2-, H95.3, I97.4-, I97.5, J95.6-, J95.7, K91.6-, L76.-, M96.-, N99.-)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| D78Intraoperative and postprocedural complications of the spleen | T80.30XSABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela | |
|---|---|---|
| Billing status | Non-billable header | Billable |
| Classification | D50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Intraoperative and postprocedural complications of the spleen is a non-billable ICD-10-CM category code (D78). | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela is a billable ICD-10-CM diagnosis code (T80.30S). |
| 7th character | — | The appropriate 7th character is to be added to each code from category T80 |
| Includes | — | complications following perfusion ABO incompatibility blood transfusion NOS Reaction to ABO incompatibility from transfusion NOS |
| Use additional code | — | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code(s) to identify the specified condition resulting from the complication code to identify devices involved and details of circumstances (Y62-Y82) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources